• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.用于体外和体内诱导性 RNA 干扰的 pINDUCER 慢病毒工具包。
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70. doi: 10.1073/pnas.1019736108. Epub 2011 Feb 9.
2
Versatile Viral Vector Strategies for Postscreening Target Validation and RNAi ON-Target Control.用于筛选后靶点验证和RNA干扰作用靶点控制的通用病毒载体策略
J Biomol Screen. 2015 Sep;20(8):976-84. doi: 10.1177/1087057115581803. Epub 2015 Apr 14.
3
Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.慢病毒载体介导的强力霉素诱导型USP39短发夹RNA或cDNA在三阴性乳腺癌细胞中的表达
Oncol Rep. 2015 May;33(5):2477-83. doi: 10.3892/or.2015.3872. Epub 2015 Mar 20.
4
Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.使用慢病毒载体递送RNAi的短期细胞毒性作用和长期不稳定性。
BMC Mol Biol. 2004 Aug 3;5:9. doi: 10.1186/1471-2199-5-9.
5
Single-vector inducible lentiviral RNAi system for oncology target validation.用于肿瘤学靶点验证的单载体诱导型慢病毒RNA干扰系统。
Cell Cycle. 2009 Feb 1;8(3):498-504. doi: 10.4161/cc.8.3.7701. Epub 2009 Feb 25.
6
An optimized lentiviral vector system for conditional RNAi and efficient cloning of microRNA embedded short hairpin RNA libraries.一种优化的慢病毒载体系统,用于条件性 RNAi 和高效克隆 miRNA 嵌入的短发夹 RNA 文库。
Biomaterials. 2017 Sep;139:102-115. doi: 10.1016/j.biomaterials.2017.05.032. Epub 2017 May 23.
7
Vector-based RNAi approaches for stable, inducible and genome-wide screens.用于稳定、可诱导和全基因组筛选的基于载体的RNA干扰方法。
Drug Discov Today. 2006 Nov;11(21-22):975-82. doi: 10.1016/j.drudis.2006.09.008. Epub 2006 Sep 26.
8
Lentivirus mediated RNA interference of EMMPRIN (CD147) gene inhibits the proliferation, matrigel invasion and tumor formation of breast cancer cells.慢病毒介导的EMMPRIN(CD147)基因RNA干扰抑制乳腺癌细胞的增殖、基质胶侵袭和肿瘤形成。
Cancer Biomark. 2016 Jul 8;17(2):237-47. doi: 10.3233/CBM-160636.
9
Lentiviral vectors encoding tetracycline-dependent repressors and transactivators for reversible knockdown of gene expression: a comparative study.用于基因表达可逆敲低的编码四环素依赖性阻遏物和反式激活因子的慢病毒载体:一项比较研究。
BMC Biotechnol. 2007 Jul 16;7:41. doi: 10.1186/1472-6750-7-41.
10
Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA.慢病毒介导的小干扰RNA传递对基因表达的调控
Cell Cycle. 2003 May-Jun;2(3):251-7.

引用本文的文献

1
The RING finger E3 ligase RNF25 protects DNA replication forks independently of its canonical roles in ubiquitin signaling.环状结构域E3连接酶RNF25独立于其在泛素信号传导中的经典作用来保护DNA复制叉。
Nat Commun. 2025 Aug 5;16(1):7214. doi: 10.1038/s41467-025-62368-8.
2
APOBEC3 mutagenesis drives therapy resistance in breast cancer.载脂蛋白B编辑酶催化多肽样蛋白3(APOBEC3)诱变导致乳腺癌产生治疗抗性。
Nat Genet. 2025 May 16. doi: 10.1038/s41588-025-02187-1.
3
A decision point between transdifferentiation and programmed cell death priming controls KRAS-dependent pancreatic cancer development.转分化与程序性细胞死亡引发之间的一个决策点控制着KRAS依赖性胰腺癌的发展。
Nat Commun. 2025 Feb 19;16(1):1765. doi: 10.1038/s41467-025-56493-7.
4
Cell enlargement modulated by GATA4 and YAP instructs the senescence-associated secretory phenotype.由GATA4和YAP调节的细胞增大决定了衰老相关分泌表型。
Nat Commun. 2025 Feb 17;16(1):1696. doi: 10.1038/s41467-025-56929-0.
5
HHV-6B ribonucleotide reductase sequesters NF-κB subunit p65 to inhibit innate immune responses.人疱疹病毒6B型核糖核苷酸还原酶隔离核因子κB亚基p65以抑制天然免疫反应。
iScience. 2024 Dec 30;28(2):111710. doi: 10.1016/j.isci.2024.111710. eCollection 2025 Feb 21.
6
IFN-γ licenses normal and pathogenic ALPK1/TIFA pathway in human monocytes.干扰素-γ激活人单核细胞中正常和致病性的ALPK1/TIFA信号通路。
iScience. 2024 Dec 10;28(1):111563. doi: 10.1016/j.isci.2024.111563. eCollection 2025 Jan 17.
7
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation.CA-125作为肾髓质癌的生物标志物:综合分子剖析、功能特征及前瞻性临床验证
Clin Cancer Res. 2025 Mar 17;31(6):1057-1068. doi: 10.1158/1078-0432.CCR-24-3324.
8
The RING Finger E3 Ligase RNF25 Protects DNA Replication Forks Independently of its Canonical Roles in Ubiquitin Signaling.环状结构域E3连接酶RNF25独立于其在泛素信号传导中的典型作用保护DNA复制叉。
bioRxiv. 2025 Jan 9:2025.01.09.632184. doi: 10.1101/2025.01.09.632184.
9
ID3 promotes erythroid differentiation and is repressed by a TAL1-PRMT6 complex.ID3促进红细胞分化,并受到TAL1-PRMT6复合物的抑制。
J Biol Chem. 2025 Feb;301(2):108119. doi: 10.1016/j.jbc.2024.108119. Epub 2024 Dec 22.
10
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM.利用CeTEAM将细胞药物靶点结合与下游药理学联系起来。
Nat Commun. 2024 Dec 6;15(1):10347. doi: 10.1038/s41467-024-54415-7.

本文引用的文献

1
Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi.使用四环素调控 RNAi 评估增殖和存活所需基因的工具包。
Nat Biotechnol. 2011 Jan;29(1):79-83. doi: 10.1038/nbt.1720. Epub 2010 Dec 5.
2
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1.系统性RNA干扰显示,致癌性KRAS驱动的癌症需要TBK1。
Nature. 2009 Nov 5;462(7269):108-12. doi: 10.1038/nature08460. Epub 2009 Oct 21.
3
In vivo RNAi screening identifies regulators of actin dynamics as key determinants of lymphoma progression.体内RNA干扰筛选确定肌动蛋白动力学调节因子是淋巴瘤进展的关键决定因素。
Nat Genet. 2009 Oct;41(10):1133-7. doi: 10.1038/ng.451. Epub 2009 Sep 27.
4
A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.一项全基因组RNA干扰筛选鉴定出了与Ras癌基因的多种合成致死相互作用。
Cell. 2009 May 29;137(5):835-48. doi: 10.1016/j.cell.2009.05.006.
5
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells.致癌性KRAS依赖性与人类癌细胞中STK33抑制之间的合成致死相互作用。
Cell. 2009 May 29;137(5):821-34. doi: 10.1016/j.cell.2009.03.017.
6
An oncogenomics-based in vivo RNAi screen identifies tumor suppressors in liver cancer.一项基于肿瘤基因组学的体内RNA干扰筛选鉴定出肝癌中的肿瘤抑制因子。
Cell. 2008 Nov 28;135(5):852-64. doi: 10.1016/j.cell.2008.09.061. Epub 2008 Nov 13.
7
Cancer proliferation gene discovery through functional genomics.通过功能基因组学发现癌症增殖基因
Science. 2008 Feb 1;319(5863):620-4. doi: 10.1126/science.1149200.
8
A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression.用于基于微小RNA的条件性RNA干扰和协调转基因表达的单一慢病毒载体平台。
Proc Natl Acad Sci U S A. 2006 Sep 12;103(37):13759-64. doi: 10.1073/pnas.0606179103. Epub 2006 Aug 31.
9
A loss-of-function RNA interference screen for molecular targets in cancer.一项针对癌症分子靶点的功能丧失型RNA干扰筛选。
Nature. 2006 May 4;441(7089):106-10. doi: 10.1038/nature04687. Epub 2006 Mar 29.
10
A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen.一种用于人类和小鼠基因的慢病毒RNA干扰文库,应用于阵列病毒高内涵筛选。
Cell. 2006 Mar 24;124(6):1283-98. doi: 10.1016/j.cell.2006.01.040.

用于体外和体内诱导性 RNA 干扰的 pINDUCER 慢病毒工具包。

The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.

机构信息

Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3665-70. doi: 10.1073/pnas.1019736108. Epub 2011 Feb 9.

DOI:10.1073/pnas.1019736108
PMID:21307310
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3048138/
Abstract

The discovery of RNAi has revolutionized loss-of-function genetic studies in mammalian systems. However, significant challenges still remain to fully exploit RNAi for mammalian genetics. For instance, genetic screens and in vivo studies could be broadly improved by methods that allow inducible and uniform gene expression control. To achieve this, we built the lentiviral pINDUCER series of expression vehicles for inducible RNAi in vivo. Using a multicistronic design, pINDUCER vehicles enable tracking of viral transduction and shRNA or cDNA induction in a broad spectrum of mammalian cell types in vivo. They achieve this uniform temporal, dose-dependent, and reversible control of gene expression across heterogenous cell populations via fluorescence-based quantification of reverse tet-transactivator expression. This feature allows isolation of cell populations that exhibit a potent, inducible target knockdown in vitro and in vivo that can be used in human xenotransplantation models to examine cancer drug targets.

摘要

RNAi 的发现彻底改变了哺乳动物系统中丧失功能的遗传研究。然而,要充分利用 RNAi 进行哺乳动物遗传学研究,仍然存在重大挑战。例如,通过允许诱导和均匀基因表达控制的方法,遗传筛选和体内研究可以得到广泛改善。为了实现这一目标,我们构建了用于体内诱导 RNAi 的慢病毒 pINDUCER 表达载体系列。使用多顺反子设计,pINDUCER 载体可在体内广泛的哺乳动物细胞类型中追踪病毒转导和 shRNA 或 cDNA 的诱导。它们通过基于荧光的逆转录转激活剂表达的定量来实现基因表达在异质细胞群体中的均匀、时间依赖性和可逆控制。这一特性允许分离出体外和体内表现出强大诱导靶基因敲低的细胞群体,可用于人类异种移植模型中检查癌症药物靶点。